HEADER HYDROLASE/HYDROLASE INHIBITOR 01-MAR-22 7X3P TITLE CRYSTAL STRUCTURE OF HUMAN SIRT5 IN COMPLEX WITH DIAZIRINE INHIBITOR 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5, MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: REGULATORY PROTEIN SIR2 HOMOLOG 5,SIR2-LIKE PROTEIN 5; COMPND 5 EC: 2.3.1.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SIRT5, SIR2L5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INHIBITOR, COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.-B.LI,J.DENG REVDAT 1 06-SEP-23 7X3P 0 JRNL AUTH G.-B.LI,J.DENG JRNL TITL CRYSTAL STRUCTURE OF HUMAN SIRT5 IN COMPLEX WITH DIAZIRINE JRNL TITL 2 INHIBITOR 9 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1-4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 40553 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.140 REMARK 3 R VALUE (WORKING SET) : 0.139 REMARK 3 FREE R VALUE : 0.163 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1187 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.1187 - 2.4759 0.98 5025 149 0.1438 0.1558 REMARK 3 2 2.4759 - 2.1631 0.98 5001 149 0.1290 0.1607 REMARK 3 3 2.1631 - 1.9654 0.98 4954 155 0.1294 0.1347 REMARK 3 4 1.9654 - 1.8245 0.97 4948 134 0.1286 0.1545 REMARK 3 5 1.8245 - 1.7170 0.97 4903 147 0.1287 0.1669 REMARK 3 6 1.7569 - 1.6805 0.93 4788 151 0.1513 0.1802 REMARK 3 7 1.7170 - 1.6310 0.96 4883 153 0.1365 0.1670 REMARK 3 8 1.6310 - 1.5600 0.96 4864 149 0.1370 0.1800 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.460 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2212 REMARK 3 ANGLE : 1.130 3001 REMARK 3 CHIRALITY : 0.062 316 REMARK 3 PLANARITY : 0.008 398 REMARK 3 DIHEDRAL : 20.509 1308 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7X3P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1300027986. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-19 REMARK 200 TEMPERATURE (KELVIN) : 198 REMARK 200 PH : 5.5-6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97919 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X CDTE 1M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41469 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 55.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 1.498 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 0.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.6.0 REMARK 200 STARTING MODEL: 6EQS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23%-27% (V/V) PEG 3350, 0.1 M MES, PH REMARK 280 5.5-6.0, 0.1-0.2 M NACL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.51700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 34 REMARK 465 ARG A 35 REMARK 465 CYS A 303 REMARK 465 HIS A 304 REMARK 465 GLU A 305 REMARK 465 ASN A 306 REMARK 465 GLU A 307 REMARK 465 THR A 308 REMARK 465 VAL A 309 REMARK 465 SER A 310 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 552 O HOH A 657 2657 2.01 REMARK 500 O HOH A 766 O HOH A 800 1556 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 78 -123.72 55.98 REMARK 500 ASN A 94 72.27 -151.03 REMARK 500 CYS A 212 -80.46 -105.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 891 DISTANCE = 6.47 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 403 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 166 SG REMARK 620 2 CYS A 169 SG 105.2 REMARK 620 3 CYS A 207 SG 107.6 111.9 REMARK 620 4 CYS A 212 SG 105.8 114.3 111.5 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: 5-[[(5~{S})-6-[[(1~{S})-1-(4-HYDROXYPHENYL)-2- REMARK 630 OXIDANYLIDENE-2-(PROP-2-YNYLAMINO)ETHYL]AMINO]-6-OXIDANYLIDENE-5- REMARK 630 [[4-[3-(TRIFLUOROMETHYL)-1,2-DIAZIRIN-3-YL]PHENYL]CARBONYLAMINO] REMARK 630 HEXYL]AMINO]-5-SULFANYLIDENE-PENTANOIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 8VG A 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 8KT 8QA D4P RRA REMARK 630 DETAILS: NULL DBREF 7X3P A 34 310 UNP Q9NXA8 SIR5_HUMAN 34 310 SEQRES 1 A 277 ALA ARG PRO SER SER SER MET ALA ASP PHE ARG LYS PHE SEQRES 2 A 277 PHE ALA LYS ALA LYS HIS ILE VAL ILE ILE SER GLY ALA SEQRES 3 A 277 GLY VAL SER ALA GLU SER GLY VAL PRO THR PHE ARG GLY SEQRES 4 A 277 ALA GLY GLY TYR TRP ARG LYS TRP GLN ALA GLN ASP LEU SEQRES 5 A 277 ALA THR PRO LEU ALA PHE ALA HIS ASN PRO SER ARG VAL SEQRES 6 A 277 TRP GLU PHE TYR HIS TYR ARG ARG GLU VAL MET GLY SER SEQRES 7 A 277 LYS GLU PRO ASN ALA GLY HIS ARG ALA ILE ALA GLU CYS SEQRES 8 A 277 GLU THR ARG LEU GLY LYS GLN GLY ARG ARG VAL VAL VAL SEQRES 9 A 277 ILE THR GLN ASN ILE ASP GLU LEU HIS ARG LYS ALA GLY SEQRES 10 A 277 THR LYS ASN LEU LEU GLU ILE HIS GLY SER LEU PHE LYS SEQRES 11 A 277 THR ARG CYS THR SER CYS GLY VAL VAL ALA GLU ASN TYR SEQRES 12 A 277 LYS SER PRO ILE CYS PRO ALA LEU SER GLY LYS GLY ALA SEQRES 13 A 277 PRO GLU PRO GLY THR GLN ASP ALA SER ILE PRO VAL GLU SEQRES 14 A 277 LYS LEU PRO ARG CYS GLU GLU ALA GLY CYS GLY GLY LEU SEQRES 15 A 277 LEU ARG PRO HIS VAL VAL TRP PHE GLY GLU ASN LEU ASP SEQRES 16 A 277 PRO ALA ILE LEU GLU GLU VAL ASP ARG GLU LEU ALA HIS SEQRES 17 A 277 CYS ASP LEU CYS LEU VAL VAL GLY THR SER SER VAL VAL SEQRES 18 A 277 TYR PRO ALA ALA MET PHE ALA PRO GLN VAL ALA ALA ARG SEQRES 19 A 277 GLY VAL PRO VAL ALA GLU PHE ASN THR GLU THR THR PRO SEQRES 20 A 277 ALA THR ASN ARG PHE ARG PHE HIS PHE GLN GLY PRO CYS SEQRES 21 A 277 GLY THR THR LEU PRO GLU ALA LEU ALA CYS HIS GLU ASN SEQRES 22 A 277 GLU THR VAL SER HET 8VG A 401 47 HET PEG A 402 7 HET ZN A 403 1 HETNAM 8VG 5-[[(5~{S})-6-[[(1~{S})-1-(4-HYDROXYPHENYL)-2- HETNAM 2 8VG OXIDANYLIDENE-2-(PROP-2-YNYLAMINO)ETHYL]AMINO]-6- HETNAM 3 8VG OXIDANYLIDENE-5-[[4-[3-(TRIFLUOROMETHYL)-1,2-DIAZIRIN- HETNAM 4 8VG 3-YL]PHENYL]CARBONYLAMINO]HEXYL]AMINO]-5- HETNAM 5 8VG SULFANYLIDENE-PENTANOIC ACID HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM ZN ZINC ION FORMUL 2 8VG C31 H33 F3 N6 O6 S FORMUL 3 PEG C4 H10 O3 FORMUL 4 ZN ZN 2+ FORMUL 5 HOH *391(H2 O) HELIX 1 AA1 SER A 39 ALA A 50 1 12 HELIX 2 AA2 GLY A 58 GLU A 64 1 7 HELIX 3 AA3 ARG A 71 GLY A 75 5 5 HELIX 4 AA4 GLN A 81 ALA A 86 1 6 HELIX 5 AA5 THR A 87 ASN A 94 1 8 HELIX 6 AA6 ASN A 94 MET A 109 1 16 HELIX 7 AA7 GLY A 110 LYS A 112 5 3 HELIX 8 AA8 ASN A 115 LYS A 130 1 16 HELIX 9 AA9 GLU A 144 GLY A 150 1 7 HELIX 10 AB1 CYS A 181 SER A 185 5 5 HELIX 11 AB2 PRO A 200 LEU A 204 5 5 HELIX 12 AB3 ASP A 228 CYS A 242 1 15 HELIX 13 AB4 PRO A 256 ALA A 258 5 3 HELIX 14 AB5 MET A 259 ARG A 267 1 9 HELIX 15 AB6 ALA A 281 PHE A 285 5 5 HELIX 16 AB7 PRO A 292 LEU A 301 1 10 SHEET 1 AA1 6 LEU A 154 GLU A 156 0 SHEET 2 AA1 6 ARG A 134 THR A 139 1 N VAL A 137 O LEU A 155 SHEET 3 AA1 6 HIS A 52 SER A 57 1 N ILE A 53 O ARG A 134 SHEET 4 AA1 6 LEU A 244 VAL A 248 1 O VAL A 248 N ILE A 56 SHEET 5 AA1 6 VAL A 271 ASN A 275 1 O ALA A 272 N CYS A 245 SHEET 6 AA1 6 PHE A 287 GLN A 290 1 O PHE A 289 N GLU A 273 SHEET 1 AA2 3 VAL A 172 GLU A 174 0 SHEET 2 AA2 3 GLY A 159 CYS A 166 -1 N THR A 164 O ALA A 173 SHEET 3 AA2 3 LEU A 216 VAL A 220 -1 O ARG A 217 N ARG A 165 LINK SG CYS A 166 ZN ZN A 403 1555 1555 2.34 LINK SG CYS A 169 ZN ZN A 403 1555 1555 2.37 LINK SG CYS A 207 ZN ZN A 403 1555 1555 2.31 LINK SG CYS A 212 ZN ZN A 403 1555 1555 2.27 CISPEP 1 SER A 178 PRO A 179 0 -6.33 CISPEP 2 TYR A 255 PRO A 256 0 0.63 CRYST1 41.332 65.034 55.658 90.00 93.58 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024194 0.000000 0.001512 0.00000 SCALE2 0.000000 0.015377 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018002 0.00000